Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT-527 in Moderate COVID-19
NCT04396106Phase 2Terminated
- Sponsor
- Atea Pharmaceuticals
- Start
- May 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of bemnifosbuvir in coronavirus disease 2019 (COVID-19), sponsored by Atea Pharmaceuticals. Started May 2020; status: terminated.
02
Drugs
bemnifosbuvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04396106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04396106.